Entering text into the input field will update the search result below

J&J, FDA close to deal allowing release of vaccine from troubled Emergent plant - WSJ

  • The FDA and Johnson & Johnson (NYSE:JNJ) are close to an announcement that millions of its doses produced at a troubled Baltimore Emergent BioSolutions (NYSE:EBS) can be released, according to The Wall Street Journal.
  • The vaccines can be distributed because

Recommended For You

Related Stocks

SymbolLast Price% Chg
JNJ
--
AZN
--
EBS
--